Unite Life Sciences, a division of IQPC, has built an active network of over 110,000 qualified executives. We are proud to deliver global insights to senior decision makers from Biotech, Pharma, Academia, Digital Health, MedTech, Investors, and Drug Regulatory Agencies.

Through unique industry led forums, market studies, reports, webinars, digital boardrooms and meetings, we are able to provide a platform for the life sciences community to do business. Let us help you build content and connections.

Download the prospectus & media kit to view our services and offerings that help you get in front of your target audience. To have a copy sent to your inbox, or to discuss sponsorship opportunities, email us at enquiry@unitelifesciences.com.

Download the current attendee snapshot for TCL - Covid19 Vaccine Manufacturing, Storage & Distribution to see which companies and industry executives you can expect to meet and network with through our live, virtual, interactive forum.

For questions or details pertaining to sponsorship/exhibition, contact us at enquiry@unitelifesciences.com

Event details: March 16-17, 2021 | Virtual Forum 

Featuring an article by Nicholas Basta, the Editor in Chief, Managing Partner and Founder of Pharmaceutical Commerce!

When it comes to safely and securely transporting high-value pharmaceutical products, the stakes couldn’t be higher. Not only is a single consignment of high-value drugs potentially worth upwards of $50 million, but, for those patients in need of these drugs, ensuring these products arrive on time and in optimal condition is quite literally a matter of life and death.

Historically, life science manufacturers have lacked the tools, resources, and technology necessary to gain full visibility into the environmental conditions their products are stored in as they traveled through the cold chain. Because data loggers only provided temperature data once the shipment had arrived at its final destination if a temperature excursion did occur, cold chain leaders could only find out after the fact. In fact, according to a 2014 study by IMS Health, the top 10 pharmaceutical companies lost an average of  $16 billion worth of product (20X the average pharma company’s price-to-earnings ratio) each year due to transportation problems, the resulting temperature excursions and other delays. For the entire pharmaceutical industry, losses exceeded $35 billion (1).

However, recent technological advancements in IoT, data management tools and connectivity have ushered in a new era of real-time temperature monitoring. Due to the emergence of better, faster and more accurate real-time monitoring tools, life sciences manufacturers can now track high-value products in real-time to ensure safe and on-time delivery.

In PART I of this whitepaper, Nick Basta of Pharmaceutical Commerce provides an overview of the evolution of real-time monitoring solutions.

PART II explores the business benefits of real-time, temperature monitoring solutions and best practices for implementations. The ideas, challenges, and solutions covered in the section were pulled from in-depth interviews with our expert speaker faculty.

If you would like a copy sent directly to you, please contact us here.

For those just starting out in temperature controlled supply, it can seem like a daunting task.

With a complex vendor landscape, pressing operational challenges and a multitude of risks factors, it is far from an easy project.

To help, we spoke to Kevin Hickman, Senior Manager of Supply Chain Distribution at Gilead Sciences. With over 26 years of experience in commercial and clinical pharma and biopharma transport management, he shares the cold chain critical success factors you need to know.

If you would like a copy sent directly to you, please contact us here.

Pharma's complicated global supply chains will undoubtedly face a slew of new and unprecedented challenges brought on by the global COVID-19 outbreak. However, big pharma is confident they’ll be able to handle the strain without sacrificing integrity. To keep you up to date on the latest developments, DOWNLOAD this abbreviated overview of how 6 pharma companies are taking on the COVID-19 pandemic.

What's trending in Temperature Control & Logistics for Life Sciences? Download our latest report to find out! 

• 2020 Industry Stats
• Regulatory Updates
• Blockchain in Brief
• Real-Time Tracking & Analytics
• New Avenues of Cost Control
• Last Mile Delivery 4.0
  

First of all, let me emphasise that the impact of COVID-19 on pharma logistics is, and will continue to be, enormous. The ease of occurrence and the pace of progression associated with this particular pandemic crisis has stunned the entire logistics sector and shocked the world. Air freight, in particular, has been hugely disrupted, and the suddenness of the situation literally caught the industry with its pants down.

Be in no doubt, the massive cutbacks we are currently seeing in air transport capacity is extremely worrying news for pharma logisticians. While medicines continue to be delivered by air with some extraordinary efforts, the current temporary air cargo boost is unsustainable without the infrastructure and effective subsidies from PAX flying. Planes are being sold and mothballed at an unprecedented rate. And not only are airlines massively cutting back, all airports are closing at least some of their doors.

These doors, along with the supporting infrastructure, may never reopen. Singapore’s Changi Airport, for example has closed its huge Terminal 2 and I understand that they are now considering mothballing Terminal 4. This is a picture that is being repeated around the world with 75% of global flight capacity currently grounded.

 With this in mind, it goes without saying that the post-pandemic pharma transportation and distribution system will need to be much more robust, resilient and diverse in order to cope with reduced air freight capacity, higher freight costs and the possibility in the future of similar emergencies and disruptive events.

Therefore a lot of changes are going to be necessary if we are to make the supply chain more shock-proof and nimble after the crisis subsides...Fill Out Form Below to Read More

In conjunction with this year’s regional and global forums on time- and temperature-controlled logistics for life sciences, IQPC has conducted a survey involving pharma manufacturers, logistics and transportation providers and packaging developers. The key takeway: the old standby term “cold chain” no longer encompasses the range of services and technologies important to the industry. And despite the flow of new technologies that have been showcased by IQPC since its first global forum, 18 years ago, there is still a strong appetite for innovation and new technology: operational managers believe that a better supply chain for time- and temperature-controlled products is possible.

DOWNLOAD our latest industry report to find out: 

• How the "cold chain" discipline is evolving 
• The top industry trends & challenges that will define the year ahead
• The key innovators driving the industry forward
• How industry leaders are building more resilient, agile and transparent supply chains

Unite Life Sciences was launched to meet needs of the rapidly evolving Life Sciences industry and Biopharma leaders. With valuable content and productive partnerships, Unite Life Sciences has built an active network of over 250,000 qualified executives. Through unique industry led Select series meetings, we are able to provide a platform for the life sciences community to do business. Download the 2021 Select Series Calendar to see what we have in store for you this year.

Shital Parikh Mars, CEO at Progressive Care, sat down with Pharma Logistics IQ, ahead of the Temperature Control and Logistics U.S. Summit, to dive into the new normal that will emerge post pandemic, how to create more resilience in the pharma supply chain and why collaboration is more important than ever before.

The pharmaceutical supply chain requires a myriad of partners to work as a cohesive unit. However, this is not always the case. Most companies have relationships built between different stakeholders at different times, competing agendas leadings to a variety of demands on vendors and an overlap of services from a lack of overarching strategy.

Together, this is creating inefficiency, hindering innovation and adding additional effort to overstretched supply chain leaders. But, there is a way for your vendors to start doing more for you, integrating more effectively with your operations and bringing forward new ideas. It simply requires collaboration.

This is often easier said that done. So we reached out to two industry experts; Bruce Guenter, Director of Logistics and Distribution at Radius Health and Rick Calabrese, Global Director of Corporate Quality Systems at Sartorius. They have shared insight with us on the steps needed to improve your vendor collaboration, how to balance the cost vs quality dynamic and where you can leverage your network to improve collaboration.